SEC Form 4 · accession 0001209191-18-063616
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Simard
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 19, 2018
Accepted (ET)
Dec 20, 2018 · 11:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 19, 2018 | M | 50,000 | $2.50 | A | 6,327,060 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $2.50 | Dec 19, 2018 | M | 50,000 | D | Jan 1, 2009 | Jan 1, 2019 | Common Stock | 50,000 | 0 | D |
Remarks
Due to stock options expiring on January 1, 2019, the Reporting Person exercised and purchased the 50,000 shares of common stock underlying these options on December 19, 2018.